| Methods of therapeutic administration of neuregulin or fragment thereof for … |
2023-4-21 |
2023-6-27 |
|
| Sustained Release Aminopyridine Composition |
2022-12-29 |
2023-5-04 |
|
| Use of neuregulin to treat peripheral nerve injury |
2022-3-28 |
2023-4-20 |
|
| Sustained release compositions of 4-aminopyridine |
2021-11-19 |
2022-10-13 |
|
| Methods of using sustained release aminopyridine compositions |
2021-11-17 |
2021-12-16 |
|
| Therapeutic dosing of neuregulin or subsequence thereof for treatment or … |
2021-11-04 |
2022-2-07 |
|
| Compositions and methods for treatment during non-acute periods following cns … |
2021-11-01 |
2021-12-02 |
|
| Sustained release compositions of 4-aminopyridine |
2021-7-13 |
2021-11-04 |
|
| Method for achieving desired glial growth factor 2 plasma levels |
2021-5-25 |
2021-6-24 |
|
| Methods of using sustained release aminopyridine compositions |
2021-5-04 |
2021-8-19 |
|
| Hepatoprotectant acetaminophen mutual prodrugs |
2020-12-04 |
2021-3-04 |
|
| Proteoglycan degrading mutants for treatment of cns |
2020-11-13 |
2021-3-25 |
|
| Compositions and kits for the removal of irritating compounds from bodily … |
2020-11-13 |
2022-12-27 |
2022-12-27 |
| Neuregulin compositions for use in treating peripheral nerve injury |
2020-9-08 |
2020-10-29 |
|
| Methods of detecting cardiac damage |
2020-7-17 |
2020-10-29 |
|
| Methods for cardiomyocyte survival, proliferation or differentiation by nrg-2 |
2020-6-05 |
2020-11-12 |
|
| Method for achieving desired glial growth factor 2 plasma levels |
2020-5-18 |
2021-3-04 |
|
| Acetaminophen conjugates, compositions and methods of use thereof |
2020-5-07 |
2020-8-13 |
|
| Carbonate prodrug and method for using the same |
2020-5-07 |
2020-8-27 |
|
| Methods and compositions for treating cns injury |
2020-4-29 |
2020-11-05 |
|
| Water-soluble acetaminophen analog |
2020-4-20 |
2020-7-30 |
|
| Methods for treating an impairment in gait and/or balance in patients with … |
2020-4-08 |
2020-7-23 |
|
| Fusion proteins for treatment of cns |
2020-2-29 |
2020-7-27 |
|
| Durable treatment with 4-aminopyridine in patients with demyelination |
2019-12-06 |
2020-4-16 |
|
| Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric … |
2019-12-06 |
2020-4-16 |
|
| Compositions and methods including a recombinant human mab that promotes cns … |
2019-9-23 |
2020-8-06 |
|
| Compositions and methods for the treatment of cns injuries |
2019-7-10 |
2020-1-16 |
|
| Method and composition for administration of trpv1 agonist |
2018-12-21 |
2019-3-22 |
|
| Formulations for the treatment of pain |
2018-8-20 |
2020-3-03 |
2020-3-03 |
| Use of potassium channel blockers to treat cerebral palsy |
2018-7-20 |
2018-12-13 |
|
| Method, apparatus and software for identifying responders in a clinical … |
2018-6-01 |
2018-9-27 |
|
| Methods for treating sensorimotor impairments associated with certain types of … |
2018-5-25 |
2018-8-16 |
|
| Methods of using sustained release aminopyridine compositions |
2018-3-12 |
2018-7-19 |
|
| Methods for treating a stroke-related sensorimotor impairment using … |
2018-1-05 |
2018-1-25 |
|
| Compositions and methods of using chondroitinase abci mutants |
2017-10-20 |
2018-3-08 |
|
| Intranasal benzodiazepine pharmaceutical compositions |
2017-9-15 |
2018-9-10 |
|
| Methods of reducing extravasation of inflammatory cells |
2017-7-17 |
2021-10-12 |
2021-10-12 |
| Compositions and Methods for Extended Therapy with Aminopyridines |
2017-5-17 |
2017-11-09 |
|
| Sustained release compositions of 4-aminopyridine |
2017-4-06 |
2018-10-11 |
|
| Chimeric protein |
2017-4-06 |
2017-11-23 |
|
| Compositions and methods of using chondroitinase abci mutants |
2016-8-05 |
2017-2-02 |
|
| Compositions and methods of using chondroitinase abci mutants |
2016-7-19 |
2018-7-05 |
2018-7-05 |
| Proteoglycan degrading mutants for treatment of cns |
2016-6-29 |
2018-3-22 |
2018-3-22 |
| Compositions and methods for promoting neuronal outgrowth |
2016-6-10 |
2016-9-29 |
|
| Rapamycin powders for pulmonary delivery |
2015-11-06 |
2016-5-12 |
|
| Dosator Apparatus for Filling a Capsule with Dry Powder |
2015-5-08 |
2015-12-03 |
|
| Methods for Reducing Inter-Patient Variability of Levodopa Plasma … |
2015-4-21 |
2016-1-21 |
|
| Methods for providing rapid relief of motor fluctuations in a parkinson's … |
2015-4-21 |
2015-11-19 |
|
| Use of a neuregulin to treat peripheral nerve injury |
2015-3-30 |
2016-10-26 |
|
| Method of reducing somnolence in patients treated with tizanidine |
2015-3-09 |
2016-2-04 |
|
| Capsules containing high doses of levodopa for pulmonary use |
2014-12-18 |
2016-7-19 |
2016-7-19 |
| Fusion proteins for the treatment of cns |
2014-11-21 |
2017-8-03 |
2017-8-03 |
| Methods for detecting cardiac damage |
2014-5-01 |
2014-5-22 |
|
| Method of increasing the extent of absorption of tizanidine |
2014-3-05 |
2015-2-05 |
|
| Compositions and methods of using chondroitinase abci mutants |
2014-1-02 |
2016-4-21 |
2016-4-21 |
| Methods for treating parkinson's disease using aminopyridines |
2013-12-11 |
2014-6-19 |
|
| Methods for improving walking capacity in patients with multiple sclerosis … |
2013-8-12 |
2014-2-20 |
|
| Methods of using sustained release aminopyridine compositions |
2013-8-12 |
2013-12-12 |
|
| Powder inhaler devices |
2013-6-28 |
2016-10-18 |
2016-10-18 |
| Method, apparatus and software for identifying responders in a clinical … |
2013-6-05 |
2013-8-22 |
|
| USE OF NEUREGULIN TO TREAT PERIPHERAL NERVE INJURY |
2013-3-29 |
2021-11-30 |
|
| Use of neuregulin to treat peripheral nerve injury |
2013-3-29 |
2019-6-28 |
|
| Proteoglycan degrading mutants for treatment of cns |
2013-2-26 |
2016-3-31 |
2016-3-31 |
| Methods for treating an impairment in gait and/or balance in patients with … |
2013-2-13 |
2018-12-21 |
|
| Devices and methods for puncturing a capsule to release a powdered medicament … |
2012-12-19 |
2014-6-05 |
|
| Methods for treating a stroke-related sensorimotor impairment using … |
2012-10-04 |
2016-11-29 |
|
| Use of 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric … |
2012-2-09 |
2012-4-30 |
|
| Use of potassium channel blockers to treat cerebral palsy |
2012-1-27 |
2018-1-04 |
|
| Use of potassium channel blockers to treat cerebral palsy |
2012-1-27 |
2017-9-29 |
|
| Method for using aminopyrine compositions with delayed release. |
2011-10-28 |
2012-3-15 |
|
| Com[positions and methods for extended therapy with aminopyridines |
2011-9-08 |
2012-11-28 |
|
| Use of 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric … |
2010-11-08 |
2015-7-10 |
|
| Use of a neuregulin to treat peripheral nerve injury |
2010-10-14 |
2022-2-01 |
|
| Use of a neuregulin to treat peripheral nerve injury |
2010-10-14 |
2022-1-06 |
|
| Use of a neuregulin to treat peripheral nerve injury |
2010-10-14 |
2021-9-24 |
|
| Use of 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric … |
2010-8-11 |
2015-10-30 |
|
| COMPOSITIONS AND METHODS FOR EXTENDED THERAPY WITH AMINOPIRIDINS |
2010-2-12 |
2011-3-30 |
|
| Methods for extended therapy with 4-aminopyridines |
2010-2-11 |
2014-1-27 |
|
| Method, apparatus and software for identifying responders in a clinical … |
2010-2-03 |
2010-8-12 |
|
| Uso de neuregulina para tratar lesão de nervo periférico |
2013-3-29 |
2021-11-30 |
|